Search results for: 'parc pois analysis for laboratory develop'

The clinical laboratory testing industry will continue to experience growth in testing volumes due to the aging of the US population, patient awareness of the benefits of laboratory testing, test cost reductions, the development of advanced and specialized tests for disease detection and management, the growing awareness of early detection and prev...

Drug-resistant bacteria, or superbugs, pose a serious threat to human health. Developing new antibacterial drugs requires a great deal of time, effort, expenditure, and scientific research, making it a less-attractive segment for investment by pharmaceutical companies. This research service focuses on the global antibacterial drugs (antibiotics) ma...

Frost & Sullivan presents post-COVID-19 growth opportunities and strategic imperatives for the global drug discovery and early development outsourcing market in this study, which covers research and development (R&D) efforts, market trends, key participants, drivers and restraints of market adoption, and recent mergers and acquisitions. The report ...

NGS library preparation incorporates processing steps that convert genomic DNA or RNA into an appropriate format for the selected sequencing technology. The workflow starts with isolating nucleic acids, fragmented, end-repaired, and connected to adapters using methods like ligation or tagmentation. Sequencing applications incorporate whole genome, ...

08 Oct 2021  |  North America  |  Market Research

Global Tissue Diagnostics (TDx) Growth Opportunities

Companion Diagnostics (CDx)-specific Advanced Staining and Anatomical Pathology Laboratory Information Systems (APLIS) to Drive Ma

Infographics

×

This research service provides an overview of the global TDx market and a 4-year forecast of it from 2021 to 2025. The market will reach $8,848.6 million in 2025, growing at a compound annual growth rate (CAGR) of 8.9% from 2020 to 2025. The advanced staining and anatomical pathology laboratory information management systems (APLIS) segments will g...

The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU laboratory information management system (LIMS) industry, highlighting the key growth opportunities, market revenue forecast, and trends that will play an important role in industry growth. The US and EU LIMS market covered in this study is segmented...

17 Jun 2021  |  North America  |  Market Research

Global Biologics Contract Development and Manufacturing Organizations Growth Opportunities

Asset Co-Development with Clinical-stage Biopharmaceutical Companies and Disruptive Technologies Present Future Growth Potential

Infographics

×

This study presents Frost & Sullivans overall market and segment-wise revenue forecasts of the global biologics contract development and manufacturing organizations (bio-CDMO) market. It also highlights key growth opportunities for bio-CDMO market participants based on the main evolution in their business models and strategic approaches, as well as...

This study covers the state of the global marine and algae oil EPA/DHA Omega-3 ingredient market, examining drivers and restraints for growth, pricing, distribution, technology, legislation, demand and geographical trends. Following from these, market growth for market segments are forecasted. In addition, an in-depth analysis of the competitive si...

The objective of this research is to analyze the growth potential of telematics-enabled usage-based insurance (UBI) service in the North American market. The study also illustrates the impact of legislations put forth in California on the total telematics-enabled UBI market. The main objective of this study is to highlight the following: The market...